Granuloma faciale in a child successfully treated with the pulsed dye laser

Welsh, Jenifer Hall; Schroeder, Theresa L.; Levy, Moise L.

doi:10.1016/s0190-9622(99)70386-5

Cited by 29 publications

(27 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The possible occurrence of multiple GF lesions is well documented and, in fact, disseminated GF has also been reported. 2,3 Facial lesions were more likely to develop on the forehead, nose, or cheeks. As previously reported, 4-8 extrafacial lesions can occur alone or in association with facial lesions, as in 5 of our patients.…”

Section: Discussionmentioning

confidence: 99%

Granuloma faciale: A clinicopathologic study of 66 patients

Ortonne¹,

Wechsler²,

Bagot³

et al. 2005

Journal of the American Academy of Dermatology

134

122

View full text Add to dashboard Cite

Section: Discussionmentioning

confidence: 99%

Granuloma faciale: A clinicopathologic study of 66 patients

Ortonne¹,

Wechsler²,

Bagot³

et al. 2005

Journal of the American Academy of Dermatology

134

122

View full text Add to dashboard Cite

“…25 In recent years, several cases have been successfully treated with a pulsed-dye laser. [26][27][28][29] We have described herein the clinicopathological features of a series of 11 patients with GF. The most significant feature was the presence of abundant fibrosis in 5 of our patients, similar to what is observed in EED.…”

Section: Discussionmentioning

confidence: 99%

Granuloma faciale: A clinicopathological study of 11 cases

Marcoval

Moreno

Peyrı́

2004

Journal of the American Academy of Dermatology

View full text Add to dashboard Cite

“…1 The first 2 reported cases of granuloma faciale successfully treated with pulsed dye laser involved an 11-year-old child and a 41-year-old man. 3,13 There are at least 8 other cases reporting a good response and 3 cases reporting a poor response to pulsed dye laser; however, complete resolution is unusual. In some cases, partial improvement was noted with potent topical corticosteroids used prior to laser therapy.…”

Section: Discussionmentioning

confidence: 99%

Complete Clearance of Resistant Granuloma Faciale With Pulsed Dye Laser After Pre-treatment With Mometasone and Tacrolimus

Micallef

Boffa

2017

J Lasers Med Sci

View full text Add to dashboard Cite

IntroductionGranuloma faciale is an uncommon, idiopathic, inflammatory dermatosis that usually affects the face.1 Despite its benign nature, the condition tends to be persistent, can be cosmetically distressing and is notoriously difficult to eradicate completely. 2 We report a case of successful treatment of granuloma faciale using 595-nm pulsed dye laser following topical mometasone and tacrolimus. Case PresentationA 39-year-old English lady with Fitzpatrick skin phototype II, presented to our Dermatology Department with 3 sharply-demarcated, reddish-brown, indurated plaques with accentuated follicular openings and few superficial telangiectases. These were present on both cheeks and the tip of the nose. The patient had been previously diagnosed with granuloma faciale in the United Kingdom 6 months previously and was started on dapsone 50 mg daily, to which there was no visible response. The patient then moved to Malta where dapsone was stopped and the lesion on the right cheek biopsied. The biopsy showed a dense neutrophilic and eosinophilic infiltrate within the papillary and reticular dermis, with a prominent Grenz zone, confirming the diagnosis of granuloma faciale. At this point, treatment with pulsed dye laser was attempted. A test area in the right cheek lesion underwent two treatments with a ScleroPlus pulsed dye laser (Candela Corporation, Wayland, Mass) with cryogenspray dynamic cooling. A wavelength of 595 nm and pulse duration of 1.5 ms were used, with a 7 mm spot at a fluence of 8.5 J/cm 2 for the first session and 9.5 J/ cm 2 for the second session, carried out after an interval of 8 weeks. There was no visible improvement with this treatment. The patient was lost to follow-up but re-presented 5 years later with the same lesions, which by then had become more prominent. She was prescribed mometasone 0.1% ointment once daily for 2 months, with no visible improvement. Tacrolimus 0.1% ointment twice daily was then added to the mometasone ointment for another 2 Case Report Abstract Introduction: Granuloma faciale is an uncommon inflammatory dermatosis which usually affects the face and is often resistant to treatment. Case Report: A 39-year-old English lady with Fitzpatrick skin phototype II presented with typical lesions of granuloma faciale, confirmed on biopsy, on her cheeks and nose. Treatment with ScleroPlus pulsed dye laser (Candela Corporation, Wayland, Mass) produced no visible improvement. The patient re-presented 5 years later with the same lesions, now more prominent. No improvement was noted with topical mometasone, however addition of topical tacrolimus caused significant flattening. Since the erythema and telangiectases persisted, treatment with ScleroPlus pulsed dye laser was re-attempted. Treatments were performed with a wavelength of 595 nm, pulse duration of 1.5 ms and 7 mm spot at a fluence of 8.5 J/cm2 in the first session and 9.5 J/cm 2 in the subsequent 2 sessions. This resulted in complete resolution without scarring or pigmentary change. There was no recurrence at follow-up ...

show abstract

Granuloma faciale in a child successfully treated with the pulsed dye laser

Cited by 29 publications

References 26 publications

Granuloma faciale: A clinicopathologic study of 66 patients

Granuloma faciale: A clinicopathologic study of 66 patients

Granuloma faciale: A clinicopathological study of 11 cases

Complete Clearance of Resistant Granuloma Faciale With Pulsed Dye Laser After Pre-treatment With Mometasone and Tacrolimus

Contact Info

Product

Resources

About